Citation profile for Eduardo Urias

Eduardo Urias : Citation Profile

Maastricht University (13% share)
United Nations University-Maastricht Economic Research Institute of Innovation and Technology (UNU-MERIT) (87% share)

H index

i10 index

Citations

RESEARCH PRODUCTION:

Articles

RESEARCH ACTIVITY:

   5 years (2015 - 2020). See details.
   Cites by year: 3
   Journals where Eduardo Urias has often published
   Relations with other researchers
   Recent citing documents: 2.    Total self citations: 2 (11.11 %)

MORE DETAILS IN:

EconPapers

ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pur38
   Updated: 2026-01-10    RAS profile: 2023-03-05
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Eduardo Urias.

Is cited by:

Besancenot, Damien (2)

Hötte, Kerstin (1)

Tobin, Damian (1)

Bustamante, Juana (1)

Grepperud, Sverre (1)

Cites to:

Lee, Keun (6)

Ramani, Shyama (4)

mu, qing (2)

Howitt, Peter (2)

Vickers, John (2)

filippetti, andrea (2)

guennif, samira (2)

Aghion, Philippe (2)

Suzigan, Wilson (2)

van der Ploeg, Frederick (Rick) (1)

Thutupalli, Ajay (1)

Main data

Where Eduardo Urias has published?

Recent works citing Eduardo Urias (2025 and 2024)

Year	Title of citing document
2024	Making intellectual property rights work for climate technology transfer and innovation in developing countries. (2024). Hötte, Kerstin ; Jee, Su Jung ; Burrell, Robert ; Hotte, Kerstin ; Ring, Caoimhe. In: Papers. RePEc:arx:papers:2408.12338. Full description at Econpapers \|\| Download paper
2024	Compulsory license threats in a signaling game of drug procurement. (2024). Besancenot, Damien ; Guennif, Samira. In: Theory and Decision. RePEc:kap:theord:v:97:y:2024:i:2:d:10.1007_s11238-024-09978-8. Full description at Econpapers \|\| Download paper

Works by Eduardo Urias:

Year	Title	Type	Cited
2018	When access to drugs meets catch-up: Insights from the use of CL threats to improve access to ARV drugs in Brazil In: Research Policy. [Full Text][Citation analysis]	article	5
2015	Access to critical medicines: When are compulsory licenses effective in price negotiations? In: Social Science & Medicine. [Full Text][Citation analysis]	article	6
2020	Access to medicines after TRIPS: Is compulsory licensing an effective mechanism to lower drug prices? A review of the existing evidence In: Journal of International Business Policy. [Full Text][Citation analysis]	article	5
2019	The potential synergies between industrial and health policies for access to medicines: insights from the Brazilian policy of universal access to HIV/AIDS treatment In: Innovation and Development. [Full Text][Citation analysis]	article	0